Search - tctmd.com

Displaying 341 - 360 of 416

Sort: Relevancy | Date

News Daily News

Hypertensive Disorders in Pregnancy Tied to Future Atrial Fibrillation

Caitlin E. Cox

February 18, 2025

News Daily News

ELASTA-Clip Plus TMVR Safe, Feasible for Failed M-TEER

Caitlin E. Cox

February 14, 2025

News Daily News

Olpasiran Cuts Lp(a) but Not Inflammatory Markers: OCEAN(a)-DOSE

Yael L. Maxwell

February 14, 2025

News Daily News

AHA Scientific Statement Takes Aim at PAD Pain

L.A. McKeown

February 13, 2025

News Daily News

Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time

Michael O'Riordan

February 13, 2025

News Conference News THT 2025

AIM-POWER: Remote, App-Based Intervention Boosts GDMT Use in HFrEF

Todd Neale

February 13, 2025

News Daily News

Acoramidis Approved in Europe for ATTR Cardiomyopathy

Michael O'Riordan

February 12, 2025

News Daily News

Intermediate Disease May Be the ‘Sweet Spot’ for T-TEER Survival Benefit

Yael L. Maxwell

February 12, 2025

Presentation THT 2025

Imaging for Assessing Heart Muscle Disease: State of the Art for Trial Endpoints, Drug Development and Clinical Practice

Presenter: Jonathan Weinsaft

February 12, 2025

Presentation THT 2025

Clinical Outcomes Among Patients With HFpEF and Peripheral Arterial Disease Undergoing Revascularization

Presenter: Phuuwadith Wattanachayakul

February 12, 2025

Presentation THT 2025

A Patient With HF and AR: How and When to Treat With TAVR and SAVR

Presenter: Torsten Vahl

February 12, 2025

Presentation THT 2025

Lessons From AVR Studies in Patients With Aortic Stenosis and Heart Failure

Presenter: Nicolas Van Mieghem

February 12, 2025

Presentation THT 2025

SMART Revisited: Contemporary Evidence for Treating AS in Patients With Small Annuli

Presenter: Howard Herrmann

February 12, 2025

Presentation THT 2025

Case Presentation for the Heart Team: A Polyvalvular Conundrum With LF-LG AS and Severe MR

Presenter: Michael Brener

February 12, 2025

Presentation THT 2025

The Percutaneous Approach: One Step at a Time…

Presenter: Mark Reisman

February 12, 2025

Presentation THT 2025

The HF Physician's Approach: GDMT - Give the Darn Medicines a Try!

Presenter: Ryan Tedford

February 12, 2025

Presentation THT 2025

The Surgical Approach: Fix 'Em All At Once!

Presenter: Gilbert Tang

February 12, 2025

Presentation THT 2025

Cardiomechanics in Patients Undergoing mTEER: Insights From PV Analysis

Presenter: Nicolas Van Mieghem

February 12, 2025

Presentation THT 2025

Strategies to Reduce the Burden of Residual MACE After mTEER in Patients With FMR

Presenter: Michael Brener

February 12, 2025

Presentation THT 2025

Pills, Drips and Pumps: Management of Volume Status and RV Dysfunction Before and After TTVI

Presenter: JoAnn Lindenfeld

February 12, 2025

Advertisement

Hypertensive Disorders in Pregnancy Tied to Future Atrial Fibrillation

ELASTA-Clip Plus TMVR Safe, Feasible for Failed M-TEER

Olpasiran Cuts Lp(a) but Not Inflammatory Markers: OCEAN(a)-DOSE

AHA Scientific Statement Takes Aim at PAD Pain

Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time

AIM-POWER: Remote, App-Based Intervention Boosts GDMT Use in HFrEF

Acoramidis Approved in Europe for ATTR Cardiomyopathy

Intermediate Disease May Be the ‘Sweet Spot’ for T-TEER Survival Benefit

Imaging for Assessing Heart Muscle Disease: State of the Art for Trial Endpoints, Drug Development and Clinical Practice

Clinical Outcomes Among Patients With HFpEF and Peripheral Arterial Disease Undergoing Revascularization

A Patient With HF and AR: How and When to Treat With TAVR and SAVR

Lessons From AVR Studies in Patients With Aortic Stenosis and Heart Failure

SMART Revisited: Contemporary Evidence for Treating AS in Patients With Small Annuli

Case Presentation for the Heart Team: A Polyvalvular Conundrum With LF-LG AS and Severe MR

The Percutaneous Approach: One Step at a Time…

The HF Physician's Approach: GDMT - Give the Darn Medicines a Try!

The Surgical Approach: Fix 'Em All At Once!

Cardiomechanics in Patients Undergoing mTEER: Insights From PV Analysis

Strategies to Reduce the Burden of Residual MACE After mTEER in Patients With FMR

Pills, Drips and Pumps: Management of Volume Status and RV Dysfunction Before and After TTVI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content